Clinical trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety and Tolerability of Bosentan in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis
NCT00070590 is registered in ClinicalTrials.gov with Actelion as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety and Tolerability of Bosentan in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis
- Lead sponsor
- Actelion
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- July 31, 2003
- Completion date
- September 30, 2005
- Enrollment
- 132
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.